The Electrodeposition of Chromium from Trivalent Salt Solutions

The enormous number of previous experiments and researches for the improvement of the commercial chromic acid bath, did not succeed even in the partial elimination of any one of the disadvantages of chromic acid bath. This led the author to believe that the poor performance is an inherent quality of the chromic acid bath, and is due to the fact that the deposition occurs from the higher state of oxidation.

Efficacy pneumococcal vaccination in adults: a meta-analysis

Background: Clinical trials and meta-analyses have produced conflicting results of the efficacy of unconjugated pneumococcal polysaccharide vaccine in adults. We sought to evaluate the vaccine’s efficacy on clinical outcomes as well as the methodologic quality of the trials. Methods: We searched several databases and all bibliographies of reviews and meta-analyses for clinical trials that compared pneumococcal polysaccharide vaccine with a control. We examined rates of pneumonia and death, taking the methodologic quality of the trials into consideration. Results: We included 22 trials involving 101 507 participants: 11 trials reported on presumptive pneumococcal pneumonia, 19 on all-cause pneumonia and 12 on allcause mortality. The current 23-valent vaccine was used in 8 trials. The relative risk (RR) was 0.64 (95% confidence interval [CI] 0.43–0.96) for presumptive pneumococcal pneumonia and 0.73 (95% CI 0.56–0.94) for all-cause pneumonia. There was significant heterogeneity between the trials reporting on presumptive pneumonia (I2 = 74%, p < 0.001) and between those reporting on all-cause pneumonia (I2 = 90%, p < 0.001). The RR for all-cause mortality was 0.97 (95% CI 0.87–1.09), with moderate heterogeneity between trials (I2 = 44%, p = 0.053). Trial quality, especially regarding double blinding, explained a substantial proportion of the heterogeneity in the trials reporting on presumptive pneumonia and all-cause pneumonia. There was little evidence of vaccine protection in trials of higher methodologic quality (RR 1.20, 95% CI 0.75–1.92, for presumptive pneumonia; and 1.19, 95% CI 0.95–1.49, for allcause pneumonia in double-blind trials; p for heterogeneity > 0.05). The results for all-cause mortality in double-blind trials were similar to those in all trials combined. There was little evidence of vaccine protection among elderly patients or adults with chronic illness in analyses of all trials (RR 1.04, 95% CI 0.78–1.38, for presumptive pneumococcal pneumonia; 0.89, 95% CI 0.69–1.14, for all-cause pneumonia; and 1.00, 95% CI 0.87–1.14, for all-cause mortality). Interpretation: Pneumococcal vaccination does not appear to be effective in preventing pneumonia, even in populations for whom the vaccine is currently recommended.

Theodor Mommsen und die Bedeutung des Römischen Rechts. Abhandlungen zum Römischen Recht und zur Antiken Rechtsgeschichte

Der Band widmet sich aus interdisziplinärer Perspektive dem altertums- und rechtswissenschaftlichen Vermächtnis von Theodor Mommsen. Im Zentrum des Interesses stehen die vielfältigen inhaltlichen und methodischen Anregungen, die Mommsens OEuvre sowohl auf die Altertums- wie auf die Rechtswissenschaft ausgeübt hat. Besonderes Augenmerk findet seine romanistische Antrittsvorlesung über »Die Bedeutung des römischen Rechts«, die der 34-jährige Gelehrte am 8. Mai 1852 an der Universität Zürich gehalten hat. Der vorliegende Band enthält die Beiträge einer internationalen Tagung, die am 11. und 12. Mai 2012 an der Universität Bern durchgeführt wurde.